NCT00208260 2026-02-05
Intensified Chemotherapy in CRC After Resection of Liver Metastases
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2/3 Completed
Clinical Trials
22 trialsNCT02494973 2024-10-28
PACHA-01
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2/3 Completed
NCT03414983 2023-11-18
CheckMate 9X8
Bristol-Myers Squibb
Phase 2/3 Completed
NCT03031444 2021-02-01
PARECEC
Peking University Cancer Hospital & Institute
Phase 2/3 Completed
NCT00212615 2020-11-06
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
Odense University Hospital
Phase 2/3 Completed
NCT00952029 2020-03-30
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT00272324 2020-03-13
Aspirin/Folate Prevention of Large Bowel Polyps
Dartmouth-Hitchcock Medical Center
Phase 2/3 Completed
NCT02332499 2019-05-21
ALTER0703
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2/3 Completed
NCT01550055 2019-04-10
CRC009
Shanghai Zhangjiang Biotechnology Limited Company
Phase 2/3 Completed
NCT02284139 2018-04-23
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
Dong-A University Hospital
Phase 2/3 Completed
NCT00384176 2017-04-14
HORIZON III
AstraZeneca
Phase 2/3 Completed
NCT01523431 2017-03-30
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2/3 Completed
NCT00153816 2017-03-15
Vitamin D/Calcium Polyp Prevention Study
Dartmouth-Hitchcock Medical Center
Phase 2/3 Completed
NCT00123760 2016-02-25
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
AHS Cancer Control Alberta
Phase 2/3 Completed
NCT01103479 2015-05-06
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Northwestern University
Phase 2/3 Completed
NCT02419677 2015-04-17
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
The First People's Hospital of Changzhou
Phase 2/3 Completed
NCT00975897 2013-12-19
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT01086618 2013-08-26
Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT00284258 2012-11-02
Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 2/3 Completed
NCT01086683 2010-03-15
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course
Danish Cancer Society
Phase 2/3 Completed
NCT00234429 2007-12-18
A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma
AstraZeneca
Phase 2/3 Completed
NCT00294359 2007-08-22
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group
Phase 2/3 Completed